Noble Life Sciences, a trusted full-service preclinical CRO, will be present at the World Vaccine Congress Meeting in Washington DC, booth 272, from 1-4 April.

We are excited to showcase our preclinical vaccine development services, including protocol development, toxicology studies, in vivo options, immunogenicity testing; immunoassays, stability testing and more at booth 272.

Pre-book a meeting time with us, or stop by Booth 272,  to explore potential collaborations and discover how our experience with animal models makes us the perfect partner to help study the effectiveness of new drugs, test for toxicity, and validate biomarkers.

We look forward to meeting you in Washington DC!